Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)
CORK, Ireland--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medici......